Skip to main content
Egyptian Liver Journal

Table 5 Univariate and multivariate regression analysis for predictors of HBV reactivation post-HCV treatment

From: Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection

 

Univariate

Multivariate

OR

95% CI

P value

OR

95% CI

P value

Age/year

1.232

0.765

1.855

0.034

1.112

0.766

1.344

0.098

Gender

1.542

0.988

1.998

0.132

    

FBS (mg/dL)

2.132

1.322

2.870

0.212

    

HB (gm/dL)

0.988

0.765

1.211

0.453

    

WBCs (103/L)

1.211

0.977

1.956

0.766

    

PLT (103/L)

3.211

1.298

4.776

0.343

    

ALT (U/L)

2.377

1.980

3.376

0.045

1.954

0.819

2.666

0.131

AST (U/L)

1.966

1.219

2.656

0.119

    

PC (%)

0.989

0.788

1.233

0.234

    

INR

1.355

1.067

1.788

0.256

    

Albumin (g/L)

2.133

1.564

2.768

0.311

    

Creatinine (mg/dL)

1.989

1.166

2.450

0.066

    

Fibroscan (Kpa)

3.420

2.786

5.144

0.112

    

Splenomegaly

2.188

1.324

2.988

0.781

    

HCV RNA level at baseline

4.343

3.299

5.321

 < 0.001

3.771

3.675

4.980

 < 0.001

Type of HCV treatment

1.324

0.944

3.217

0.536

    
  1. OR Odds ratio, significant, FBS Fasting blood sugar, WBCs White blood cells, ALT Alanine aminotransferase, AST Aspartate aminotransferase, PC Prothrombin concentration, INR International normalized ratio, kPa Kilopascal, HBC Hepatitis B virus, HCV Hepatitis C virus, RNA Ribonucleic acid
Back to article page